首页> 美国卫生研究院文献>Journal of Medical Genetics >Heterogeneity of familial porphyria cutanea tarda.
【2h】

Heterogeneity of familial porphyria cutanea tarda.

机译:家族性卟啉单胞菌的异质性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The concentration of immunoreactive uroporphyrinogen decarboxylase has been measured in erythrocytes from 17 patients with porphyria cutanea tarda (PCT) from 10 families, from 74 of their relatives, and from 47 control subjects. The 10 families were divided into two groups according to their erythrocyte enzyme concentrations. Group A contained four families in which at least two subjects had overt PCT. All members of these families, including seven patients with overt PCT, had normal erythrocyte uroporphyrinogen decarboxylase concentrations and activities. Apart from their family history, patients in group A were clinically and biochemically indistinguishable from cases of type I (sporadic) PCT. Group B contained six families with the only previously described form of familial PCT (type II PCT) in which decreased erythrocyte uroporphyrinogen decarboxylase segregates as an autosomal dominant trait. These findings show that familial PCT is heterogeneous and suggest that inheritance contributes to the pathogenesis of at least some cases of type I PCT.
机译:已测量了来自10个家庭,其74个亲属和47个对照对象的17例皮肤卟啉卟啉症(PCT)患者的红细胞中免疫反应性尿卟啉原脱羧酶的浓度。根据其红细胞酶浓度将10个科分为两组。 A组包含四个科,其中至少两个科目具有公开的PCT。这些家族的所有成员,包括7名明显的PCT患者,都具有正常的红细胞尿卟啉原脱羧酶浓度和活性。除家族史外,A组患者在临床和生化上与I型(散发)PCT病例没有区别。 B组包含六个家族,具有先前描述的家族式PCT(II型PCT)形式,其中减少的红细胞尿卟啉原脱羧酶作为常染色体显性性状分离。这些发现表明家族性PCT是异质性的,并且表明遗传至少在某些I型PCT病例的发病机理中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号